56 related articles for article (PubMed ID: 8019022)
1. Calcium channel blockers in kidney transplantation.
Ladefoged SD; Andersen CB
Clin Transplant; 1994 Apr; 8(2 Pt 1):128-33. PubMed ID: 8019022
[TBL] [Abstract][Full Text] [Related]
2. Effect of nifedipine on renal allograft function and survival beyond one year.
Shin GT; Cheigh JS; Riggio RR; Suthanthiran M; Stubenbord WT; Serur D; Wang JC; Rubin AL; Stenzel KH
Clin Nephrol; 1997 Jan; 47(1):33-6. PubMed ID: 9021239
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients.
Hillebrand U; Suwelack BM; Loley K; Lang D; Reuter S; Amler S; Pavenstädt H; Hausberg M; Büssemaker E
Transpl Int; 2009 Nov; 22(11):1073-80. PubMed ID: 19624495
[TBL] [Abstract][Full Text] [Related]
4. Role of calcium channel blockers in diabetic renal transplant patients: preliminary observations on protection from sepsis.
Weinrauch LA; D'Elia JA; Gleason RE; Shaffer D; Monaco AP
Clin Nephrol; 1995 Sep; 44(3):185-92. PubMed ID: 8556835
[TBL] [Abstract][Full Text] [Related]
5. Delayed graft function of cadaveric renal transplants is prevented by diltiazem.
Carmellini M; Salvadori M; Di Stefano R; Bertoni E; Nicita G; Rosati A; Taddei G; Rindi P; Rizzo G; Mosca F
Transplant Proc; 1996 Feb; 28(1):80-2. PubMed ID: 8644348
[No Abstract] [Full Text] [Related]
6. Improved outcome of cadaveric renal transplantation due to calcium channel blockers.
Palmer BF; Dawidson I; Sagalowsky A; Sandor Z; Lu CY
Transplantation; 1991 Oct; 52(4):640-5. PubMed ID: 1926343
[TBL] [Abstract][Full Text] [Related]
7. Improvement in renal function by felodipine during cyclosporine treatment in acute and short-term studies.
Pedersen EB; Madsen JK; Sørensen SS; Zachariae H
Kidney Int Suppl; 1996 Jun; 55():S94-6. PubMed ID: 8743522
[TBL] [Abstract][Full Text] [Related]
8. Effect of calcium channel blockers on graft outcome in cyclosporine-treated renal allograft recipients.
Vasquez EM; Pollak R
Transplantation; 1995 Oct; 60(8):885-7. PubMed ID: 7482755
[No Abstract] [Full Text] [Related]
9. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
10. Addition of isradipine (Lomir) results in a better renal function after kidney transplantation: a double-blind, randomized, placebo-controlled, multi-center study.
van Riemsdijk IC; Mulder PG; de Fijter JW; Bruijn JA; van Hooff JP; Hoitsma AJ; Tegzess AM; Weimar W
Transplantation; 2000 Jul; 70(1):122-6. PubMed ID: 10919587
[TBL] [Abstract][Full Text] [Related]
11. Renal transplants with delayed graft function show decreased renal function despite monitoring with postabsorptive levels.
Dominguez J; Gonzalez A; Crossley N; Norambuena R
Transplant Proc; 2004; 36(6):1655-8. PubMed ID: 15350442
[TBL] [Abstract][Full Text] [Related]
12. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
Vathsala A; Woo KT
Clin Transpl; 1999; ():189-97. PubMed ID: 11038637
[TBL] [Abstract][Full Text] [Related]
13. Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: a prospective randomized placebo-controlled 2-year study.
Kuypers DR; Neumayer HH; Fritsche L; Budde K; Rodicio JL; Vanrenterghem Y;
Transplantation; 2004 Oct; 78(8):1204-11. PubMed ID: 15502721
[TBL] [Abstract][Full Text] [Related]
14. Graft outcome in cadaver renal transplants treated with full-dose cyclosporine induction without antibody, irrespective of graft function.
Douzdjian V; Bhaskar S; Baliga PK; Rajagopalan PR
Clin Transplant; 1997 Aug; 11(4):294-8. PubMed ID: 9267718
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
Aichberger C; Eberl T; Riedmann B; Pernthaler H; Ofner D; Königsrainer A; Margreiter R
Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
[TBL] [Abstract][Full Text] [Related]
16. The long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart beating donors.
Fukuhara N; Ono Y; Hattori R; Nishiyama N; Yamada S; Kamihira O; Kinukawa T; Ohshima S
Clin Transplant; 2005 Apr; 19(2):153-7. PubMed ID: 15740548
[TBL] [Abstract][Full Text] [Related]
17. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
Mota A
Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of calcium antagonists on cyclosporin nephrotoxicity after clinical renal transplantation.
Morales JM; Andres A; Rodicio JL
Nephrol Dial Transplant; 1993; 8(9):880. PubMed ID: 8255527
[No Abstract] [Full Text] [Related]
19. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
Nashan B
Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
[TBL] [Abstract][Full Text] [Related]
20. Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era.
Hariharan S; Alexander JW; Schroeder TJ; First MR
Clin Transplant; 1996 Apr; 10(2):186-90. PubMed ID: 8664516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
